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mice in urinary fluid excretion, plasma Ca 2+ concentration, plasma phosphate concentration and urinary Ca 2+ output. The urinary phosphate output was significantly lower in Anx7 -/-mice than in Anx7 +/+ mice. Conclusion: Annexin A7 deficiency upregulates FGF23 plasma levels, an effect paralleled by increased corticosterone plasma levels, as well as decreased 1,25(OH) 2 D 3 and PTH plasma levels.
Introduction
FGF23 (fibroblast growth factor 23), a powerful regulator of calcium and phosphate metabolism [1, 2] decreases the formation of 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) by down-regulation of renal 1α hydroxylase (Cyp27b1) and fosters the inactivation of 1,25(OH) 2 D 3 by up-regulation of 25-hydroxyvitamin D 24-hydroxylase (Cyp24a1) [3] [4] [5] [6] . FGF23 thus lowers serum levels of 1,25(OH) 2 D 3 [5] [6] [7] [8] [9] [10] [11] [12] , which in turn up-regulates renal and intestinal phosphate and calcium transport [13] [14] [15] [16] . Beyond its effect on 1,25(OH) 2 D 3 metabolism, FGF23 inhibits more directly renal tubular phosphate reabsorption [2, 5, 7, 8, [10] [11] [12] 17] thus enhancing renal phosphate elimination [5, 7, 8, [10] [11] [12] . FGF23 deficiency is thus followed by increased serum 1,25(OH) 2 D 3 , phosphate and calcium concentration, profuse tissue calcification, accelerated aging and reduction of lifespan [4, 12, [18] [19] [20] [21] .
Several effects of FGF23 require Klotho as a co-receptor [22] [23] [24] . Similar to FGF23 deficient mice, Klotho deficient mice suffer from tissue calcification, rapid aging and early death [22, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] , resulting from increased 1,25(OH) 2 D 3 formation, enhanced renal tubular phosphate reabsorption and increased serum phosphate levels [40] [41] [42] .
Stimulators of FGF23 release include 1,25(OH) 2 D 3 [24, 43] , PHEX (phosphateregulating gene with homology to endopeptidase) [24] , DMP-1 (dentin matrix protein or cyclin D binding myb-like protein 1) [24] , sustained phosphate load even in the absence of hyperphosphatemia [24] , increased extracellular Ca 2+ concentration [24] , parathyroid hormone [24] , and lithium [44] .
Cellular mechanisms governing FGF23 release include increase of cytosolic Ca 2+ activity following stimulation of store operated Ca 2+ entry (SOCE) [45] [46] [47] . Orai1, the pore forming channel protein accomplishing SOCE is upregulated by the serum & glucocorticoid inducible kinase SGK1 [48] [49] [50] [51] . As SGK1 is upregulated by glucocorticoids [52] , FGF23 may be sensitive to glucocorticoid action. As a matter of fact, glucocorticoids do increase FGF23 release [53, 54] .
Modifiers of glucocorticoid effects include annexin A7 [55] , a member of a large family of ubiquitously expressed Ca
2+
-and phospholipid-binding intracellular proteins [56] [57] [58] [59] [60] , which are involved in the regulation of a wide variety of functions including inhibition of phospholipase A 2 [61, 62] . Gene targeted mice lacking functional annexin A7 suffer from excessive formation of PGE 2 [63] , disorders of cardiac excitation [64, 65] , enhanced glial cell proliferation [66] , accelerated suicidal erythrocyte death [67] and resistance towards the stimulation of glucocorticoids on gastric acid secretion [55] .
We hypothesized that SGK1 dependent regulation of FGF23 release could be sensitive to annexin A7. We thus explored whether annexin A7-deficiency impacts on FGF23 plasma concentrations.
Materials and Methods

Mice
All animal experiments were conducted according to the German law for the welfare of animals and were approved by the responsible authorities of the state of Baden-Württemberg (Regierungspräsidium Tübingen). Experiments were performed in gene-targeted mice lacking annexin A7 (Anx7 -/-) and in corresponding wild type mice (Anx7 +/+ ). Generation, properties and genotyping of Anx7 -/-mice were described earlier [64] . The male age-matched mice (9-15 weeks old) used for the experiments had free access to standard chow (SSniff, Soest, Germany) and tap water ad libitum.
Determination of serum and plasma hormone concentrations
To collect blood specimens, animals were lightly anesthetized and about 50 -200 μl of blood was withdrawn by puncturing the retro-orbital plexus [68] . Serum C-terminal FGF23 and serum intact FGF23 (Immutopics International, San Clemente, CA, USA), serum 1,25(OH) 2 D 3 (IDS, Boldon, UK), plasma intact PTH (Immunotopics, San Clemante, USA), and serum corticosterone (IBL, Hamburg, Germany) concentrations were measured by enzyme-linked immunosorbent assay (ELISA) or EIA according to the manufacturer 's instructions. The serum phosphate and ionized Ca 2+ concentrations were measured by a flame photometer (Eppendorf, Hamburg, Germany).
Measurement of urinary calcium and phosphate concentrations
For determination of urinary parameters, the mice were placed individually in metabolic cages (Techniplast, Hohenpeissenberg, Germany) for 24 h collection of urine [69] . To assure quantitative urine collection, metabolic cages were siliconized, and urine was collected under water-saturated oil.
The urinary phosphate concentration was determined colorimetrically utilizing a commercial diagnostic kit (Roche Diagnostics, Mannheim, Germany). Urinary calcium was measured by flame photometry (Eppendorf, Hamburg, Germany).
Statistics
Data are provided as means ± SEM, n represents the number of independent experiments. All data were tested for significance using Student t-test. Only results with p < 0.05 were considered statistically significant.
Results
The present study compared FGF23 plasma levels and calcium phosphate metabolism in Anx7 -/-and Anx7 +/+ mice. As illustrated in Fig.1 , serum C-terminal FGF23 levels were significantly higher in Anx7 -/-than in Anx7 +/+ mice. Intact FGF23 serum levels similarly tended to be higher in Anx7 -/-than in Anx7 +/+ mice, a difference, however, not reaching statistical significance. At least in theory, the increased FGF23 level in Anx7 -/-mice could have resulted from enhanced stimulation by 1,25(OH) 2 D 3 and/or PTH. Thus the serum concentrations of 1,25(OH) 2 D 3 and of PTH were determined. As illustrated in Fig. 2A, serum 1 (Fig. 2B) . In order to test whether annexin A7 deficiency affects glucocorticoid release, plasma corticosterone levels were determined. As illustrated in Fig.3 , serum corticosterone levels were significantly higher in Anx7 -/-mice than in Anx7 +/+ mice. Further experiments explored whether the differences in hormone levels between anx7 -/-and Anx7 +/+ mice affected plasma concentrations and urinary output of Ca 2+ and/or phosphate. To this end, the animals were placed in metabolic cages. As illustrated in Fig.4 , water intake was slightly but significantly higher in Anx7 -/-mice than in Anx7 +/+ mice (Fig.  4A ). No significant difference was observed in urinary fluid excretion (Fig. 4B) , food intake (Fig. 4C) , and body weigth (Fig. 4D) between Anx7 -/-and Anx7 +/+ mice. (Fig. 5C ). The urinary phosphate output was, however, significantly lower in Anx7 -/-mice than in Anx7 +/+ mice (Fig. 5D) . serum & glucocorticoid inducible kinase (SGK1), a kinase participating in the regulation of FGF23 formation [45] . SGK1 is in turn at least in part effective by increasing store operated Ca 2+ entry [45] [46] [47] .
The enhanced FGF23 plasma level in Anx7 -/-mice explains the decreased plasma 1,25(OH) 2 D 3 levels, as FGF23 downregulates 1α hydroxylase, CYp27b1 and thus 1,25(OH) 2 D 3 formation [3, 5] . For its effect, FGF23 requires Klotho as a co-receptor [22, 70] . As a negative feedback, 1,25(OH) 2 D 3 stimulates the release of FGF23 [71] .
The significantly decreased urinary phosphate output in Anx7 -/-mice is presumably a result of decreased formation of 1,25(OH) 2 D 3 , a stimulator of intestinal phosphate transport [13] . FGF23, on the other hand, was expected to trigger phosphaturia as it decreases renal tubular phosphate reabsorption by inhibiting 1,25(OH) 2 D 3 formation and Na + -coupled phosphate transport in proximal renal tubules [2, 5] . It must further be kept in mind that renal Ca 2+ and phosphate excretion are modified by glucocorticoids [72] [73] [74] [75] .
Conclusion
The present observations reveal that lack of annexin A7 results in increased plasma FGF23 levels, an effect possibly in part due to enhanced corticosterone release, and 
Discussion
The present observations reveal that annexin A7 deficiency leads to enhanced plasma FGF23 concentration, which is paralleled by increased plasma corticosterone levels, significantly decreased serum 1,25(OH) 2 D 3 and PTH levels, significantly enhanced water intake and significantly decreased urinary phosphate output.
The increased FGF23 formation in Anx7 -/-mice could possibly be due to increased plasma corticosterone levels, as, similar to mineralocorticoids [45] glucocorticoids are known to up-regulate FGF23 release [53, 54] . Glucocorticoids and mineralocorticoids are presumably effective by up-regulating the
